Eryn Callihan
Impact in
-
- Cancer Risks and Factors
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Global Cancer Incidence and Screening
-
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 2
- Cancer Risks and Factors 2
- Cancer Diagnosis and Treatment 1
-
- Renal cell carcinoma treatment 2
- Prostate Cancer Treatment and Research 1
- Prostate Cancer Diagnosis and Treatment 1
- Co-authors
- Virginia F. Borges (3 shared papers)Dexiang Gao (3 shared papers)Pepper Schedin (2 shared papers)Sonali Jindal (1 shared paper)Traci R. Lyons (1 shared paper)Susan M. Edgerton (1 shared paper)Óscar Ramírez (1 shared paper)Rodabe N. Amaria (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)European Journal of Cancer (1 paper)Breast Cancer Research and Treatment (1 paper)Cancer Immunology Immunotherapy (1 paper)Current Oncology Reports (1 paper)
- Partner nations
- United States
In The Last Decade
Eryn Callihan
8 papers receiving 299 citations
Peers
Comparison fields: 5 of 43
- Oncology 195
- Immunology 113
- Cancer Research 26
- Pediatrics, Perinatology and Child Health 21
- Epidemiology 31
Countries citing papers authored by Eryn Callihan
This map shows the geographic impact of Eryn Callihan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eryn Callihan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eryn Callihan more than expected).
Fields of papers citing papers by Eryn Callihan
This network shows the impact of papers produced by Eryn Callihan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eryn Callihan. The network helps show where Eryn Callihan may publish in the future.
Co-authors
The 25 scholars most cited alongside Eryn Callihan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 153 | |
| 2 | 2013 | 113 | |
| 3 | 2022 | 17 | |
| 4 | 2021 | 6 | |
| 5 | 2021 | 5 | |
| 6 | 2023 | 4 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 1 |
About Eryn Callihan
Eryn Callihan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Epidemiology and Economics and Econometrics, having authored 8 papers that have together received 303 indexed citations. Recurring topics across this work include Multiple and Secondary Primary Cancers (2 papers), Renal cell carcinoma treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Risks and Factors (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Cancer Diagnosis and Treatment (1 paper), Prostate Cancer Treatment and Research (1 paper) and Prostate Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (195 citations), Immunology (113 citations), Cancer Research (26 citations), Pediatrics, Perinatology and Child Health (21 citations) and Epidemiology (31 citations). Eryn Callihan has collaborated with scholars based in United States. Frequent co-authors include Virginia F. Borges, Dexiang Gao, Pepper Schedin, Sonali Jindal, Traci R. Lyons, Susan M. Edgerton, Óscar Ramírez, Rodabe N. Amaria, Martin D. McCarter and Kimberly R. Jordan. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Breast Cancer Research and Treatment, Cancer Immunology Immunotherapy and Current Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.